Replimune Group, Inc. Gains 85.68%

Replimune Group, Inc. (REPL:NASDAQ) rocketted at $8.69, a gain of 85.7%. On Fri, May 29, 2026, REPL:NASDAQ hit a New 2-Week High of $8.69. The stock got featured on our News Catalysts scanner on Fri, May 29, 2026 at 02:41 PM in the 'AGREEMENT' category. From Fri, May 15, 2026, the stock recorded 44.44% Up Days and 50.00% Green Days

The stock spiked on Mon, Mar 09, 2026 at $9.1 with a volume of 3M+.

About Replimune Group, Inc. (REPL:NASDAQ)

Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.